Prenetics Global (NASDAQ:PRE – Get Rating) and AltEnergy Acquisition (NASDAQ:AEAE – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.
Volatility and Risk
Prenetics Global has a beta of -0.61, suggesting that its share price is 161% less volatile than the S&P 500. Comparatively, AltEnergy Acquisition has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500.
This table compares Prenetics Global and AltEnergy Acquisition’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Prenetics Global currently has a consensus price target of $7.00, indicating a potential upside of 665.03%. Given Prenetics Global’s higher possible upside, analysts plainly believe Prenetics Global is more favorable than AltEnergy Acquisition.
Insider & Institutional Ownership
13.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 69.0% of AltEnergy Acquisition shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by company insiders. Comparatively, 20.0% of AltEnergy Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Prenetics Global and AltEnergy Acquisition’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Prenetics Global||$275.76 million||0.45||-$190.45 million||($5.32)||-0.17|
AltEnergy Acquisition has lower revenue, but higher earnings than Prenetics Global.
AltEnergy Acquisition beats Prenetics Global on 6 of the 9 factors compared between the two stocks.
About Prenetics Global
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
About AltEnergy Acquisition
AltEnergy Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar transaction with one or more businesses. It intends to acquire and operate businesses in the renewable energy or related clean technology sectors. AltEnergy Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.